Insider Cluster (2 insiders) ·Filed Jul 16, 2026

MLYS

Mineralys Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $679K total
Actionable Insight • Neutral

Sales are immaterial relative to market cap and consistent with post-vesting liquidity. No bearish signal. Monitor next quarterly filing for any change in insider sentiment or material corporate developments.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
MLYS ▼ -3.66% at T+20d
NEUTRAL call ✗ call lost -3.66% · α vs SPY -7.27% · entry $27.08 → $26.09
Next anchor: T+60d in 6d
Latest observation: T+52 +11.88% FF3 residual α
Entry anchored
Jul 15, 03:59 PM ET
via exchange tick
T+1d
+0.04%
call +0.04% · α +1.03%
$27.09
settled 3mo ago
T+5d
-0.30%
call -0.30% · α +1.38%
$27.00
settled 2mo ago
T+20d
-3.66%
call -3.66% · α -7.27%
$26.09
settled 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

CEO Jon Congleton and CMO David Malcom Rodman sold a combined $679K of MLYS stock in open-market sales on July 13, 2026, following derivative exercises by the CMO. At a $2.3B market cap, the sales represent ~0.03% of market cap — well below the 0.1% threshold for materiality. The CMO's exercises were non-cash events; the sales appear to be routine post-vesting liquidity transactions, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$679.0K
Insiders
2

Key Facts

  • CEO Jon Congleton sold 10,700 shares at $27.24 for $291K on July 13, 2026.
  • CMO David Malcom Rodman sold 14,058 shares at $27.58 for $388K on July 13, 2026.
  • CMO also exercised multiple derivative tranches (non-cash) on July 13, 2026.
  • Total open-market sales: $679K, representing ~0.03% of MLYS's $2.3B market cap.
  • No insider purchases were reported in the cluster window.

Financial Impact

Total insider sales of $679K represent ~0.03% of market cap — trivial and routine.

insider ownership

Risk Factors

  • Insider sales could increase if additional vesting events occur.
  • No purchases to offset the selling pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MLYS-1784163533883
22 reports for MLYS
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+20▲ +20.97%Jun 11, 2026
Filters
Rows
Reports for MLYS — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
3
NEUTRAL ★ 2/10
$26.09 $28.20▲ +8.09%▲ +9.83%$23.56 (−9.70%)
Jul 23, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.71 $25.65▼ −3.97%▼ −7.59%$23.56 (−11.79%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.52 $26.61▼ −3.31%▼ −5.87%$23.56 (−14.39%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.08 $26.09▼ −3.66%▼ −7.27%$23.56 (−13.00%)
Jun 30, 2026
13w ago
144
NEUTRAL ★ 3/10
$26.89 $26.35▼ −2.01%▲ +0.18%$23.56 (−12.38%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 3/10
$26.88 $26.71▼ −0.63%▼ −0.35%$23.56 (−12.35%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.63 $27.08▲ +9.95%▲ +9.41%$23.56 (−4.34%)
Jun 17, 2026
15w ago
144
NEUTRAL ★ 2/10
$24.63 $27.08▲ +9.95%▲ +9.41%$23.56 (−4.34%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$23.94 $28.96▲ +20.97%▲ +19.08%$23.56 (−1.59%)
Jun 3, 2026
17w ago
8-K
MIXED ★ 7/10
$25.06 $27.69▲ +10.49%▲ +11.49%$23.56 (−5.99%)
Showing 10 of 22

US Market Status

Market Open — Closes in 3h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 16, 2026